Deep search
All
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
TODAY on MSN
30m
FDA approves first nasal spray treatment for severe depression
The FDA approved Johnson & Johnson’s Spravato nasal spray as a stand-alone treatment for patients suffering from severe ...
Hosted on MSN
24m
Can Lexapro Cause Weight Loss? What to Know
If you’ve been diagnosed with major depressive disorder or a form of anxiety, your mental health provider may prescribe the ...
pharmaphorum
57m
The future of precision psychiatry
The mental health clinical trials market is expected to double to $4.27 billion in 2028, up from $2.15 billion in 2018, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Los Angeles wildfire updates
California fires: How to help
Prince Harry settles suit
Soda button reinstalled
Turns down plea deal
Faces new allegations
Murder charge upheld
The Band's keyboardist dies
Meta ex-COO sanctioned
Files $500M defamation suit
Bryan pastor found guilty
Can target schools, churches
Silk Road founder pardoned
Voice of Navy football dies
1st Japanese elected to HOF
Wildfires near San Diego
Raising prices again
SCOTUS grants new hearing
FDA approves nasal spray
'Days of Our Lives' star dies
Doug Collins hearing
Antisemitism lawsuits settled
Discuss strengthening ties
Birthright citizenship suit
Trailblazing cartoonist dies
Released from prison
Israel’s top general resigns
Related topics
Johnson & Johnson
Spravato
Food and Drug Administration
Feedback